← All indications
Sezary Syndrome
A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells).
Drugs by status
Approved for this indication (1)
Phase 4 trials (2)
Phase 3 trials (2)
Phase 2 trials (63)
- methylprednisolone
- resimmune
- atezolizumab
- urea
- bendamustine
- brentuximab vedotin
- busulfan
- lenalidomide
- nelarabine
- doxycycline
- durvalumab
- famitinib
- gemcitabine
- tacrolimus
- naltrexone
- aldesleukin
- beclomethasone
- nivolumab
- iph4102
- pembrolizumab
- methoxsalen
- msk-2206
- o6-benzylguanine
- panobinostat
- ritlecitinib
- carmustine
- ifosfamide
- ipilimumab
- carboplatin
- interleukin-12
- +33 more
Phase 1 trials (46)
- fau
- azacitidine
- dexrazoxane
- alvespimycin
- avelumab
- belinostat
- irinotecan
- carfilzomib
- cilengitide
- devimistat
- doxorubicin
- duvelisib
- entinostat
- folic acid
- imatinib
- ar-42
- cyanocobalamin
- in111 anti-cd45 monoclonal antibody bc8
- methoxyamine
- alisertib
- morab-004
- vincristine
- pralatrexate
- methylene blue
- sunitinib
- interleukin-15
- ro4929097
- silicon phthalocyanine
- bevacizumab
- tanespimycin
- +16 more
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (47)
- 4SC AG
- Seattle Genetics
- Celgene
- Millennium Pharmaceuticals
- Roche
- Merck
- Genzyme
- Angimmune LLC
- Innate Pharma
- Mallinckrodt
- Neumedicines Inc.
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Pennsylvania
- University of Pittsburgh
- Cancer and Leukemia Group B (CALGB)
- Case Western Reserve University
- University of London
- Cornell University
- Emory University
- University of Washington
- James Graham Brown Cancer Center
- Latin American Cooperative Onco-Haematology Group - Peru
- Northwestern University
- Ohio State University
- Rutgers University
- Stanford University
- Thomas Jefferson University
- University of Manchester
- University of Medicine and Dentistry of New Jersey
- +17 more
Organization Involved with Phase 1 Indications (15)
- Spectrum Pharmaceuticals
- Amgen
- Morphotek
- Eli Lilly
- Arno Therapeutics
- AIDS Malignancy Consortium
- Johns Hopkins University
- Southwest Oncology Group
- Virginia Commonwealth University
- Wake Forest University
- Wayne State University
- University of Colorado, Denver
- University of North Carolina at Chapel Hill
- University of Wisconsin
- St. Jude Children's Hospital